What's more, numerous very well recognized adverse prognostic markers, which include U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, shed their destructive influence in individuals handled with VO. The one component that remained predictive of a shorter progression-free survival During this cohort of people was TP53 aberrations.112 Last but not l